Publication | Open Access
Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment Advancements
17
Citations
38
References
2023
Year
Myasthenia gravis is an autoimmune disorder caused by antibodies that attack the neuromuscular junction. These antibodies target and damage postsynaptic components by binding to the postsynaptic muscle end-plate, leading to disrupted signal transmission and resulting in muscle weakness and fatigue. Advances in understanding the immunological mechanisms behind myasthenia gravis have led to the development of targeted immunotherapies. This review examines the subgroups of myasthenia gravis, therap
| Year | Citations | |
|---|---|---|
Page 1
Page 1